Turning Point Therapeutics, Inc. TPTX
75.49 +75.49
Day range unavailable
52-week range unavailable
Revenue & Expenses
Latest period ending Dec 31, 2021 · select a line to chart its full history
Income statement
| Fiscal year | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 | FY 2017 Dec 31, 2017 |
|---|---|---|---|---|---|
| 30.83M | 25.00M | 0 | 0 | 0 | |
| 30.83M | 25.00M | 0 | 0 | 0 | |
| -238.00M | -161.84M | -77.72M | -25.64M | -16.73M | |
| -236.55M | -157.29M | -72.13M | -24.79M | -16.59M | |
| -4.80 | -3.85 | -2.99 | -7.31 | -4.97 |
Balance sheet
| Fiscal year | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 | FY 2017 Dec 31, 2017 |
|---|---|---|---|---|---|
| 427.88M | 554.10M | 48.19M | 101.03M | 45.03M | |
| 1.00B | 1.14B | 422.20M | 103.28M | 45.91M | |
| 49.04M | 26.82M | 17.85M | 151.69M | 70.75M | |
| 5.58M | 3.82M | 5.05M | 0 | 0 | |
| 954.42M | 1.11B | 404.35M | -48.41M | -24.84M |
Cash flow
| Fiscal year | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 | FY 2017 Dec 31, 2017 |
|---|---|---|---|---|---|
| -153.88M | -82.79M | -57.68M | -23.53M | -12.64M | |
| 5.46M | -210.03M | -361.08M | -302.00K | -88.00K | |
| 24.00M | 798.74M | 366.00M | 79.83M | 44.85M | |
| -2.43M | -1.26M | -1.74M | -302.00K | -88.00K | |
| -124.42M | 505.91M | -52.77M | 56.00M | 32.12M |